Decisions on funding drug for Friedreich’s Ataxia and rubber-stamping cuts to excise duty a likely inducement for costly politiking

The row over Skyclarys, a new drug for Friedreich’s ataxia patients, was the political story of the week

Decisions on funding drug for Friedreich’s Ataxia and rubber-stamping cuts to excise duty a likely inducement for costly politiking